Senate Patent Bill To Boost Biosimilars Needs Work, Attys Say
A new Senate bill to create a patent framework for biosimilars akin to the Hatch-Waxman system for generic drugs could clarify the biosimilar approval process, but attorneys say it may conflict...To view the full article, register now.
Already a subscriber? Click here to view full article